Laquinimod ameliorates spontaneous colitis in interleukin-10-gene-deficient mice with improved barrier function

Our results indicated that laquinimod treatment ameliorates colitis in Il10−/− mice and improves intestinal barrier function, which may support a new therapeutic approach to Crohn's disease.